$8.75
-0.150 (-1.69%)
At Close: Jun 03, 2026
ARS Pharmaceuticals stock falls toward record selloff after FDA issues surprise CRL, requesting additional studies
06:21am, Wednesday, 20'th Sep 2023
Sharesof ARS Pharmaceuticals Inc. SPRY plunged 46.9% toward a 15-month low in premarket trading Wednesday, after the biopharmaceutical company said the U.S. Food and Drug Administration issued a Compl
ARS Pharma (SPRY) Gets FDA Panel Vote for Epinephrine Nasal Spray
03:59pm, Monday, 15'th May 2023
ARS Pharmaceuticals (SPRY) gains as it gets favorable votes from the FDA advisory committee for epinephrine spray to treat severe allergic reactions.
Sign In
Buy SPRY